Acumen Pharmaceuticals
ABOS
ABOS
81 hedge funds and large institutions have $44.8M invested in Acumen Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 33 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
39% less capital invested
Capital invested by funds: $73.2M → $44.8M (-$28.3M)
55% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 33
Holders
81
Holding in Top 10
–
Calls
$45K
Puts
$67K
Top Buyers
| 1 | +$685K | |
| 2 | +$154K | |
| 3 | +$78.6K | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$74.1K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$59.6K |
Top Sellers
| 1 | -$3.16M | |
| 2 | -$299K | |
| 3 | -$188K | |
| 4 |
Morgan Stanley
New York
|
-$162K |
| 5 |
JP Morgan Chase
New York
|
-$151K |